Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance
Lactate has recently been reported to accumulate in the livers of patients progressing from simple steatosis to non-alcoholic steatohepatitis (NASH). However, the underlying mechanism(s) of lactate accumulation and the role of lactate in the progression of non-alcoholic fatty liver disease (NAFLD) a...
Gespeichert in:
Veröffentlicht in: | Journal of hepatology 2021-05, Vol.74 (5), p.1038 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 5 |
container_start_page | 1038 |
container_title | Journal of hepatology |
container_volume | 74 |
creator | Wang, Tongxin Chen, Kai Yao, Weilei Zheng, Ruilong He, Qiongyu Xia, Jun Li, Juan Shao, Yafei Zhang, Li Huang, Lu Qin, Longshan Xu, Mingming Zhang, Zheng Pan, Dingyu Li, Zhen Huang, Feiruo |
description | Lactate has recently been reported to accumulate in the livers of patients progressing from simple steatosis to non-alcoholic steatohepatitis (NASH). However, the underlying mechanism(s) of lactate accumulation and the role of lactate in the progression of non-alcoholic fatty liver disease (NAFLD) are essentially unknown.
We compared the acetylome in liver samples taken from healthy individuals, patients with simple steatosis and patients with NASH to identify potential targets of acetylation with a role in lactate metabolism. Interactions between the acetylated target and acetyltransferases were measured in multiple cell lines. An acetyltransferase inhibitor was injected into high-fat diet (HFD)-fed mice to determine the role of lactate on NAFLD progression in vivo.
Hyperacetylation of lactate dehydrogenase B (LDHB) was found to be associated with lactate accumulation in NAFL and NASH livers in humans and mice. P300/CBP-associated factor (PCAF)-mediated acetylation of LDHB K82 was found to significantly decrease LDHB activity and impair hepatic lactate clearance, resulting in lactate accumulation. Acetylated LDHB induced lactate accumulation which exacerbated lipid deposition and inflammatory responses by activating histone hyperacetylation in HFD-induced NASH. The administration of embelin, a PCAF inhibitor, and the generation of an acetylation-deficient mutant of LDHB ameliorated NASH.
PCAF-dependent LDHB acetylation plays a key role in hepatic lipid accumulation and inflammatory responses by impairing lactate clearance; this process might be a potential therapeutic target for the treatment of NASH.
Lactate is known to accumulate in the livers of patients during the progression of non-alcoholic fatty liver disease (NAFLD); however, the underlying mechanism(s) of this accumulation and its importance in disease progression are unknown. Herein, we show that the acetylation of an enzyme involved in lactate metabolism leads to impaired lactate clearance and exacerbates NAFLD progression. |
doi_str_mv | 10.1016/j.jhep.2020.11.028 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2465447600</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2553567910</sourcerecordid><originalsourceid>FETCH-LOGICAL-c288t-e122d5eca50b41e440532b35d3bb6d673f6a7636f7b097d00ad9a4db0ad427803</originalsourceid><addsrcrecordid>eNpdkDtPw0AQhE8IRELgD1AgSzQ0NntP22UIBJAiaKDFOvvWiS2_8NlI_vdcRKCgWmnnm9XsEHJJIaBA1W0ZlDvsAgbMLWgALDoic6oAfFCCHpO5gyI_YmE0I2fWlgDAIRanZMY5E5ET5-RjmeEwVXoo2sZrc6_S2aAH9AzuJtO3W2y0Re_OM33xhdZ7Wa43917nhB6t3XvSySvqThd90Wz_3FmFutdNhufkJNeVxYvDXJD39cPb6snfvD4-r5YbP2NRNPhIGTMSMy0hFRSFAMlZyqXhaaqMCnmudKi4ysMU4tAAaBNrYVI3hXsP-ILc_Nx10T5HtENSFzbDqtINtqNNmFBSiNB149Drf2jZjn3j0iVMSi5VGNM9dXWgxrRGk3R9Uet-Sn6b49925HCA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2553567910</pqid></control><display><type>article</type><title>Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wang, Tongxin ; Chen, Kai ; Yao, Weilei ; Zheng, Ruilong ; He, Qiongyu ; Xia, Jun ; Li, Juan ; Shao, Yafei ; Zhang, Li ; Huang, Lu ; Qin, Longshan ; Xu, Mingming ; Zhang, Zheng ; Pan, Dingyu ; Li, Zhen ; Huang, Feiruo</creator><creatorcontrib>Wang, Tongxin ; Chen, Kai ; Yao, Weilei ; Zheng, Ruilong ; He, Qiongyu ; Xia, Jun ; Li, Juan ; Shao, Yafei ; Zhang, Li ; Huang, Lu ; Qin, Longshan ; Xu, Mingming ; Zhang, Zheng ; Pan, Dingyu ; Li, Zhen ; Huang, Feiruo</creatorcontrib><description>Lactate has recently been reported to accumulate in the livers of patients progressing from simple steatosis to non-alcoholic steatohepatitis (NASH). However, the underlying mechanism(s) of lactate accumulation and the role of lactate in the progression of non-alcoholic fatty liver disease (NAFLD) are essentially unknown.
We compared the acetylome in liver samples taken from healthy individuals, patients with simple steatosis and patients with NASH to identify potential targets of acetylation with a role in lactate metabolism. Interactions between the acetylated target and acetyltransferases were measured in multiple cell lines. An acetyltransferase inhibitor was injected into high-fat diet (HFD)-fed mice to determine the role of lactate on NAFLD progression in vivo.
Hyperacetylation of lactate dehydrogenase B (LDHB) was found to be associated with lactate accumulation in NAFL and NASH livers in humans and mice. P300/CBP-associated factor (PCAF)-mediated acetylation of LDHB K82 was found to significantly decrease LDHB activity and impair hepatic lactate clearance, resulting in lactate accumulation. Acetylated LDHB induced lactate accumulation which exacerbated lipid deposition and inflammatory responses by activating histone hyperacetylation in HFD-induced NASH. The administration of embelin, a PCAF inhibitor, and the generation of an acetylation-deficient mutant of LDHB ameliorated NASH.
PCAF-dependent LDHB acetylation plays a key role in hepatic lipid accumulation and inflammatory responses by impairing lactate clearance; this process might be a potential therapeutic target for the treatment of NASH.
Lactate is known to accumulate in the livers of patients during the progression of non-alcoholic fatty liver disease (NAFLD); however, the underlying mechanism(s) of this accumulation and its importance in disease progression are unknown. Herein, we show that the acetylation of an enzyme involved in lactate metabolism leads to impaired lactate clearance and exacerbates NAFLD progression.</description><identifier>ISSN: 0168-8278</identifier><identifier>ISSN: 1600-0641</identifier><identifier>EISSN: 1600-0641</identifier><identifier>DOI: 10.1016/j.jhep.2020.11.028</identifier><identifier>PMID: 33248168</identifier><language>eng</language><publisher>Netherlands: Elsevier Science Ltd</publisher><subject>Acetylation ; Acetyltransferase ; Acetyltransferases - antagonists & inhibitors ; Acetyltransferases - metabolism ; Animals ; Cell Line ; Cell lines ; Deficient mutant ; Dehydrogenases ; Disease Progression ; Fatty liver ; Hepatobiliary Elimination - physiology ; High fat diet ; Histones ; Humans ; Inflammation ; Isoenzymes - metabolism ; L-Lactate dehydrogenase ; L-Lactate Dehydrogenase - metabolism ; Lactic acid ; Lactic Acid - metabolism ; Liver - metabolism ; Liver - pathology ; Liver diseases ; Metabolism ; Mice ; Non-alcoholic Fatty Liver Disease - metabolism ; p300-CBP Transcription Factors - metabolism ; Patients ; Steatosis ; Therapeutic targets ; Tissue Distribution - physiology</subject><ispartof>Journal of hepatology, 2021-05, Vol.74 (5), p.1038</ispartof><rights>Copyright © 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. May 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c288t-e122d5eca50b41e440532b35d3bb6d673f6a7636f7b097d00ad9a4db0ad427803</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33248168$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Tongxin</creatorcontrib><creatorcontrib>Chen, Kai</creatorcontrib><creatorcontrib>Yao, Weilei</creatorcontrib><creatorcontrib>Zheng, Ruilong</creatorcontrib><creatorcontrib>He, Qiongyu</creatorcontrib><creatorcontrib>Xia, Jun</creatorcontrib><creatorcontrib>Li, Juan</creatorcontrib><creatorcontrib>Shao, Yafei</creatorcontrib><creatorcontrib>Zhang, Li</creatorcontrib><creatorcontrib>Huang, Lu</creatorcontrib><creatorcontrib>Qin, Longshan</creatorcontrib><creatorcontrib>Xu, Mingming</creatorcontrib><creatorcontrib>Zhang, Zheng</creatorcontrib><creatorcontrib>Pan, Dingyu</creatorcontrib><creatorcontrib>Li, Zhen</creatorcontrib><creatorcontrib>Huang, Feiruo</creatorcontrib><title>Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance</title><title>Journal of hepatology</title><addtitle>J Hepatol</addtitle><description>Lactate has recently been reported to accumulate in the livers of patients progressing from simple steatosis to non-alcoholic steatohepatitis (NASH). However, the underlying mechanism(s) of lactate accumulation and the role of lactate in the progression of non-alcoholic fatty liver disease (NAFLD) are essentially unknown.
We compared the acetylome in liver samples taken from healthy individuals, patients with simple steatosis and patients with NASH to identify potential targets of acetylation with a role in lactate metabolism. Interactions between the acetylated target and acetyltransferases were measured in multiple cell lines. An acetyltransferase inhibitor was injected into high-fat diet (HFD)-fed mice to determine the role of lactate on NAFLD progression in vivo.
Hyperacetylation of lactate dehydrogenase B (LDHB) was found to be associated with lactate accumulation in NAFL and NASH livers in humans and mice. P300/CBP-associated factor (PCAF)-mediated acetylation of LDHB K82 was found to significantly decrease LDHB activity and impair hepatic lactate clearance, resulting in lactate accumulation. Acetylated LDHB induced lactate accumulation which exacerbated lipid deposition and inflammatory responses by activating histone hyperacetylation in HFD-induced NASH. The administration of embelin, a PCAF inhibitor, and the generation of an acetylation-deficient mutant of LDHB ameliorated NASH.
PCAF-dependent LDHB acetylation plays a key role in hepatic lipid accumulation and inflammatory responses by impairing lactate clearance; this process might be a potential therapeutic target for the treatment of NASH.
Lactate is known to accumulate in the livers of patients during the progression of non-alcoholic fatty liver disease (NAFLD); however, the underlying mechanism(s) of this accumulation and its importance in disease progression are unknown. Herein, we show that the acetylation of an enzyme involved in lactate metabolism leads to impaired lactate clearance and exacerbates NAFLD progression.</description><subject>Acetylation</subject><subject>Acetyltransferase</subject><subject>Acetyltransferases - antagonists & inhibitors</subject><subject>Acetyltransferases - metabolism</subject><subject>Animals</subject><subject>Cell Line</subject><subject>Cell lines</subject><subject>Deficient mutant</subject><subject>Dehydrogenases</subject><subject>Disease Progression</subject><subject>Fatty liver</subject><subject>Hepatobiliary Elimination - physiology</subject><subject>High fat diet</subject><subject>Histones</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Isoenzymes - metabolism</subject><subject>L-Lactate dehydrogenase</subject><subject>L-Lactate Dehydrogenase - metabolism</subject><subject>Lactic acid</subject><subject>Lactic Acid - metabolism</subject><subject>Liver - metabolism</subject><subject>Liver - pathology</subject><subject>Liver diseases</subject><subject>Metabolism</subject><subject>Mice</subject><subject>Non-alcoholic Fatty Liver Disease - metabolism</subject><subject>p300-CBP Transcription Factors - metabolism</subject><subject>Patients</subject><subject>Steatosis</subject><subject>Therapeutic targets</subject><subject>Tissue Distribution - physiology</subject><issn>0168-8278</issn><issn>1600-0641</issn><issn>1600-0641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkDtPw0AQhE8IRELgD1AgSzQ0NntP22UIBJAiaKDFOvvWiS2_8NlI_vdcRKCgWmnnm9XsEHJJIaBA1W0ZlDvsAgbMLWgALDoic6oAfFCCHpO5gyI_YmE0I2fWlgDAIRanZMY5E5ET5-RjmeEwVXoo2sZrc6_S2aAH9AzuJtO3W2y0Re_OM33xhdZ7Wa43917nhB6t3XvSySvqThd90Wz_3FmFutdNhufkJNeVxYvDXJD39cPb6snfvD4-r5YbP2NRNPhIGTMSMy0hFRSFAMlZyqXhaaqMCnmudKi4ysMU4tAAaBNrYVI3hXsP-ILc_Nx10T5HtENSFzbDqtINtqNNmFBSiNB149Drf2jZjn3j0iVMSi5VGNM9dXWgxrRGk3R9Uet-Sn6b49925HCA</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Wang, Tongxin</creator><creator>Chen, Kai</creator><creator>Yao, Weilei</creator><creator>Zheng, Ruilong</creator><creator>He, Qiongyu</creator><creator>Xia, Jun</creator><creator>Li, Juan</creator><creator>Shao, Yafei</creator><creator>Zhang, Li</creator><creator>Huang, Lu</creator><creator>Qin, Longshan</creator><creator>Xu, Mingming</creator><creator>Zhang, Zheng</creator><creator>Pan, Dingyu</creator><creator>Li, Zhen</creator><creator>Huang, Feiruo</creator><general>Elsevier Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>202105</creationdate><title>Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance</title><author>Wang, Tongxin ; Chen, Kai ; Yao, Weilei ; Zheng, Ruilong ; He, Qiongyu ; Xia, Jun ; Li, Juan ; Shao, Yafei ; Zhang, Li ; Huang, Lu ; Qin, Longshan ; Xu, Mingming ; Zhang, Zheng ; Pan, Dingyu ; Li, Zhen ; Huang, Feiruo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c288t-e122d5eca50b41e440532b35d3bb6d673f6a7636f7b097d00ad9a4db0ad427803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acetylation</topic><topic>Acetyltransferase</topic><topic>Acetyltransferases - antagonists & inhibitors</topic><topic>Acetyltransferases - metabolism</topic><topic>Animals</topic><topic>Cell Line</topic><topic>Cell lines</topic><topic>Deficient mutant</topic><topic>Dehydrogenases</topic><topic>Disease Progression</topic><topic>Fatty liver</topic><topic>Hepatobiliary Elimination - physiology</topic><topic>High fat diet</topic><topic>Histones</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Isoenzymes - metabolism</topic><topic>L-Lactate dehydrogenase</topic><topic>L-Lactate Dehydrogenase - metabolism</topic><topic>Lactic acid</topic><topic>Lactic Acid - metabolism</topic><topic>Liver - metabolism</topic><topic>Liver - pathology</topic><topic>Liver diseases</topic><topic>Metabolism</topic><topic>Mice</topic><topic>Non-alcoholic Fatty Liver Disease - metabolism</topic><topic>p300-CBP Transcription Factors - metabolism</topic><topic>Patients</topic><topic>Steatosis</topic><topic>Therapeutic targets</topic><topic>Tissue Distribution - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Tongxin</creatorcontrib><creatorcontrib>Chen, Kai</creatorcontrib><creatorcontrib>Yao, Weilei</creatorcontrib><creatorcontrib>Zheng, Ruilong</creatorcontrib><creatorcontrib>He, Qiongyu</creatorcontrib><creatorcontrib>Xia, Jun</creatorcontrib><creatorcontrib>Li, Juan</creatorcontrib><creatorcontrib>Shao, Yafei</creatorcontrib><creatorcontrib>Zhang, Li</creatorcontrib><creatorcontrib>Huang, Lu</creatorcontrib><creatorcontrib>Qin, Longshan</creatorcontrib><creatorcontrib>Xu, Mingming</creatorcontrib><creatorcontrib>Zhang, Zheng</creatorcontrib><creatorcontrib>Pan, Dingyu</creatorcontrib><creatorcontrib>Li, Zhen</creatorcontrib><creatorcontrib>Huang, Feiruo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Tongxin</au><au>Chen, Kai</au><au>Yao, Weilei</au><au>Zheng, Ruilong</au><au>He, Qiongyu</au><au>Xia, Jun</au><au>Li, Juan</au><au>Shao, Yafei</au><au>Zhang, Li</au><au>Huang, Lu</au><au>Qin, Longshan</au><au>Xu, Mingming</au><au>Zhang, Zheng</au><au>Pan, Dingyu</au><au>Li, Zhen</au><au>Huang, Feiruo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance</atitle><jtitle>Journal of hepatology</jtitle><addtitle>J Hepatol</addtitle><date>2021-05</date><risdate>2021</risdate><volume>74</volume><issue>5</issue><spage>1038</spage><pages>1038-</pages><issn>0168-8278</issn><issn>1600-0641</issn><eissn>1600-0641</eissn><abstract>Lactate has recently been reported to accumulate in the livers of patients progressing from simple steatosis to non-alcoholic steatohepatitis (NASH). However, the underlying mechanism(s) of lactate accumulation and the role of lactate in the progression of non-alcoholic fatty liver disease (NAFLD) are essentially unknown.
We compared the acetylome in liver samples taken from healthy individuals, patients with simple steatosis and patients with NASH to identify potential targets of acetylation with a role in lactate metabolism. Interactions between the acetylated target and acetyltransferases were measured in multiple cell lines. An acetyltransferase inhibitor was injected into high-fat diet (HFD)-fed mice to determine the role of lactate on NAFLD progression in vivo.
Hyperacetylation of lactate dehydrogenase B (LDHB) was found to be associated with lactate accumulation in NAFL and NASH livers in humans and mice. P300/CBP-associated factor (PCAF)-mediated acetylation of LDHB K82 was found to significantly decrease LDHB activity and impair hepatic lactate clearance, resulting in lactate accumulation. Acetylated LDHB induced lactate accumulation which exacerbated lipid deposition and inflammatory responses by activating histone hyperacetylation in HFD-induced NASH. The administration of embelin, a PCAF inhibitor, and the generation of an acetylation-deficient mutant of LDHB ameliorated NASH.
PCAF-dependent LDHB acetylation plays a key role in hepatic lipid accumulation and inflammatory responses by impairing lactate clearance; this process might be a potential therapeutic target for the treatment of NASH.
Lactate is known to accumulate in the livers of patients during the progression of non-alcoholic fatty liver disease (NAFLD); however, the underlying mechanism(s) of this accumulation and its importance in disease progression are unknown. Herein, we show that the acetylation of an enzyme involved in lactate metabolism leads to impaired lactate clearance and exacerbates NAFLD progression.</abstract><cop>Netherlands</cop><pub>Elsevier Science Ltd</pub><pmid>33248168</pmid><doi>10.1016/j.jhep.2020.11.028</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0168-8278 |
ispartof | Journal of hepatology, 2021-05, Vol.74 (5), p.1038 |
issn | 0168-8278 1600-0641 1600-0641 |
language | eng |
recordid | cdi_proquest_miscellaneous_2465447600 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Acetylation Acetyltransferase Acetyltransferases - antagonists & inhibitors Acetyltransferases - metabolism Animals Cell Line Cell lines Deficient mutant Dehydrogenases Disease Progression Fatty liver Hepatobiliary Elimination - physiology High fat diet Histones Humans Inflammation Isoenzymes - metabolism L-Lactate dehydrogenase L-Lactate Dehydrogenase - metabolism Lactic acid Lactic Acid - metabolism Liver - metabolism Liver - pathology Liver diseases Metabolism Mice Non-alcoholic Fatty Liver Disease - metabolism p300-CBP Transcription Factors - metabolism Patients Steatosis Therapeutic targets Tissue Distribution - physiology |
title | Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T22%3A53%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acetylation%20of%20lactate%20dehydrogenase%20B%20drives%20NAFLD%20progression%20by%20impairing%20lactate%20clearance&rft.jtitle=Journal%20of%20hepatology&rft.au=Wang,%20Tongxin&rft.date=2021-05&rft.volume=74&rft.issue=5&rft.spage=1038&rft.pages=1038-&rft.issn=0168-8278&rft.eissn=1600-0641&rft_id=info:doi/10.1016/j.jhep.2020.11.028&rft_dat=%3Cproquest_pubme%3E2553567910%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2553567910&rft_id=info:pmid/33248168&rfr_iscdi=true |